Holocene Advisors, LP Kura Oncology, Inc. Transaction History
Holocene Advisors, LP
- $29.2 Billion
- Q4 2024
A detailed history of Holocene Advisors, LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Holocene Advisors, LP holds 226,895 shares of KURA stock, worth $1.88 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
226,895
Previous 2,689,456
91.56%
Holding current value
$1.88 Million
Previous $52.6 Million
96.24%
% of portfolio
0.01%
Previous 0.23%
Shares
14 transactions
Others Institutions Holding KURA
# of Institutions
196Shares Held
79.6MCall Options Held
98.7KPut Options Held
70.1K-
Black Rock Inc. New York, NY6.97MShares$57.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.8MShares$48 Million0.71% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.08MShares$42 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$39.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.45MShares$36.9 Million0.63% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $554M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...